Insulin-Mediated Signaling Facilitates Resistance to PDGFR Inhibition in Proneural hPDGFB-Driven Gliomas

Damian A Almiron Bonnin1,2, Cong Ran1,2, Matthew C Havrda1,2

  • 1Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.

Insights

Therapeutic resistance in glioblastoma (GBM) involves insulin receptor (IR)/insulin growth-like factor receptor (IGF1R) signaling. Targeting IR/IGF1R alongside PDGFR may overcome resistance to receptor tyrosine kinase inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Receptor tyrosine kinases (RTKs), including platelet-derived growth factor receptor (PDGFR), are implicated in glioblastoma (GBM) pathogenesis.
  • Therapeutic resistance to RTK inhibitors is a major clinical challenge in treating GBM.

Purpose of the Study:

  • To investigate the mechanisms of therapeutic resistance in proneural gliomas driven by PDGFR signaling.
  • To identify alternative therapeutic targets to overcome resistance to PDGFR inhibition.

Main Methods:

  • Utilized a genetically engineered mouse model of proneural glioma that develops resistance to PDGFR inhibition.
  • Assessed the role of insulin receptor (IR)/insulin growth-like factor receptor (IGF1R) signaling in resistant tumor cells.
  • Evaluated the efficacy of cotargeting IR/IGF1R and PDGFR in vitro.

Main Results:

  • Tumors resistant to PDGFR inhibition showed dependence on IR/IGF1R signaling for proliferation and survival.
  • Cotargeting IR/IGF1R and PDGFR significantly reduced the emergence of resistant clones in vitro.

Conclusions:

  • The IR/IGF1R signaling axis is a key mediator of resistance to PDGFR inhibition in a subset of gliomas.
  • IR/IGF1R signaling is crucial for glioma recurrence, particularly in the proneural subtype.
  • Combined inhibition of IR/IGF1R and PDGFR presents a potential strategy to overcome therapeutic resistance in GBM.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K